The University of Liverpool is leading a £2.7 million clinical trial to investigate vagus nerve stimulation as a treatment for people with drug-resistant epilepsy.
Research has found that low-intensity transcranial ultrasound stimulation can modulate brain activity and behaviours, supporting the observations of psychiatric conditions.
Wearable devices are being used as part of a cardiology programme “Our Hearts Our Minds” to support patients at risk of, or who have a cardiovascular condition.
Alzheimer’s disease, a growing silent pandemic, is discussed here by Project Alzheimer’s Value Europe (PAVE), who introduce their stakeholder forum that focuses on developing new research in the field, such as emerging therapeutic & diagnostic innovations.
Shiao Fong Yee, Marketing Communications Manager at Novacyt Group, discusses the importance of rapid testing to differentiate between COVID-19 and other infections in light of facing winter respiratory viral challenges.
A US study found higher blood pressure levels were associated with the COVID-19 pandemic, due to stay-at-home orders impacting healthy lifestyle behaviours.
Nordic countries are typically associated with high standards of living, high investment in the public health sector and low population density. Here, Biljana Stangeland...
Pascale V Guillot from Elizabeth Garrett Anderson Institute for Women’s Health, provides further analysis of stem cell therapy for brittle bone disease
A new study estimates HIV disproportionately affects trans feminine women, with 20% of trans feminine individuals being positive with the virus, highlighting the need for prevention efforts and appropriate sex education.
Dr Dan Williams, SynaptixBio CEO, discusses the search to find the first treatment for one of the world’s rarest diseases, TUBB4A-associated leukodystrophy
